Cumberland Pharmaceuticals (CPIX) Assets (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Assets data on file, last reported at $71.0 million in Q1 2026.

• For the quarter ending Q1 2026, Assets rose 1.51% year-over-year to $71.0 million; the trailing twelve-month figure through Mar 2026 stood at $71.0 million (up 1.51% YoY), and the FY2025 full-year result was $76.8 million, up 1.64% from the prior year.
• Assets declined to $71.0 million in Q1 2026, from $76.8 million in the prior quarter.
• In the past five years, Assets ranged from a high of $96.7 million in Q1 2022 to a low of $65.9 million in Q3 2025.
• A 5-year average of $81.5 million and a median of $81.5 million in 2024 frame the typical range for Assets.
• Across the five-year window, Assets advanced 10.02% in 2022 and dropped 14.2% in 2025, its largest moves.
• Tracing CPIX's Assets over 5 years: stood at $92.9 million in 2022, then dropped by 12.0% to $81.8 million in 2023, then decreased by 7.57% to $75.6 million in 2024, then climbed by 1.64% to $76.8 million in 2025, then fell by 7.59% to $71.0 million in 2026.
• Business Quant data shows CPIX's Assets at $71.0 million in Q1 2026, $76.8 million in Q4 2025, and $65.9 million in Q3 2025.